Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2013-03-14 Regulatory Filings
Country SE Sweden
Listing ST EKTA

About Elekta

https://www.elekta.com/

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Denmark’s Odense University Hospital Orders Elekta’s New Versa HD Linear Accelerator for Radiotherapy Treatment of Patients with Cancer
Regulatory Filings Classification · 1% confidence The document announces a specific business event: Odense University Hospital ordering two Versa HD radiation therapy systems from Elekta. It details the product features, quotes hospital staff, and concludes with contact information for Investor Relations and Public Relations, noting that the information is being made public in accordance with securities acts. This type of announcement, focusing on a significant commercial contract or business development that is material to investors but is not a formal financial report (like 10-K or IR) or a standard earnings release (ER), typically falls under general regulatory announcements or news releases. Since it is a specific, non-financial-result-focused announcement, and it is not a proxy statement (DEF 14A), director dealing (DIRS), or capital change (CAP), the most appropriate general category for a significant, non-standard corporate news item is Regulatory Filings (RNS), which serves as a broad category for material news releases not covered by more specific codes.
2013-03-14 English
Odense Universitetssjukhus i Danmark beställer Elektas nya strålterapissystem Versa HD™
Regulatory Filings Classification · 1% confidence The document is a press release announcing a specific business event: Odense University Hospital ordering two Versa HD radiation therapy systems from Elekta. It details the product features, includes quotes from a hospital official and mentions investor relations contacts. The concluding paragraph states: "Informationen lämnades för offentliggörande den 14 mars 2013 kl. 07.30 CET," which is characteristic of a formal regulatory announcement intended for immediate public disclosure, often preceding or accompanying a formal filing. Since it is a general announcement about a business development (not strictly financial results, management change, or capital structure), and it is a formal press release format, it fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory announcement, or potentially a 'Report Publication Announcement' (RPA) if it were announcing the release of a report, which it is not. Given the context of immediate public disclosure of significant news, RNS is the most appropriate general category for non-standardized announcements.
2013-03-14 Swedish
Kuopio universitetssjukhus först i Finland med Elektas nya strålformeringslösning
Regulatory Filings Classification · 1% confidence The document is a press release from Elekta AB, dated March 6, 2013, announcing that Kuopio University Hospital is implementing new Elekta radiation therapy systems (Elekta Infinity with Agility collimator). It details the technical benefits and future plans for the hospital. Crucially, the text ends with a standard disclosure: "Informationen är sådan som Elekta AB (publ) ska offentliggöra enligt lagen om handel med finansiella instrument och/eller lagen om värdepappersmarknaden. Informationen lämnades för offentliggörande den 6 mars 2013 kl. 08.00 CET." This structure—a news announcement followed by a regulatory disclosure statement regarding financial instruments law—indicates a general regulatory announcement rather than a specific periodic report (like 10-K or IR) or a specific corporate action (like DIV or CAP). Since it is a general announcement that doesn't fit the highly specific categories (like DIRS, MANG, or DIV), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (3758 chars), and it functions as an announcement of news/technology adoption, not a detailed financial report.
2013-03-06 Swedish
Kuopio University Hospital First in Finland with Elekta’s New Beam Shaping Innovation for Radiotherapy of Cancer Patients
Regulatory Filings Classification · 1% confidence The document is a press release announcing a specific operational update: Kuopio University Hospital acquiring and implementing new radiotherapy equipment (Elekta Infinity systems with Agility MLC). It includes quotes, technical details about the equipment, and contact information for Investor Relations and Public Relations. Crucially, the final paragraph states: "The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act." This structure strongly indicates a formal regulatory announcement intended for immediate public disclosure, but it is not a standard financial report (like 10-K, IR, or ER). Since it is a general, non-financial-specific regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), the most appropriate classification is the general regulatory filing fallback category, RNS (Regulatory Filings). The document length is short (3771 chars), but it is the primary announcement itself, not an announcement *about* another report, so the RPA rule does not strictly apply here, favoring RNS for a general regulatory disclosure.
2013-03-06 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report May – January 2012/13' and contains detailed financial statements, including group summaries, order bookings, net sales, earnings, and liquidity analysis for the nine-month period. It provides substantive financial data and management commentary, fitting the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report (RPA) as it contains the full financial data itself. 9M 2013
2013-03-05 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period May 2012 to January 2013. It contains comprehensive financial statements, including income statements, balance sheet summaries, and management commentary on business performance, regional market developments, and financial outlook. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2013
2013-03-05 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.